Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis
- PMID: 33831962
- DOI: 10.1055/a-1477-4027
Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis
Conflict of interest statement
V.M., S.M., B.K.T., and J.-C.L. have no conflict of interest. S.P. is clinician-scientist of the Fonds de Recherche en Santé du Québec and has received research grants from Actelion Pharmaceuticals, AstraZeneca, and Resverlogix outside of the submitted work.
Comment on
-
Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.Thromb Haemost. 2021 Jan;121(1):76-85. doi: 10.1055/s-0040-1721664. Epub 2020 Dec 30. Thromb Haemost. 2021. PMID: 33378787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
